ArticleHaematologica2022

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.

Jun-Ichi Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.